Journal
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH
Volume 14, Issue 6, Pages 835-842Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/14737167.2014.963558
Keywords
cancer; costs; financial burden; medical decision-making; patient education
Funding
- Novartis
Ask authors/readers for more resources
Patients in the USA face potentially high financial burdens from the costs of cancer care, distinct from the challenges of societal costs and the economic impact of the disease itself. Survey data suggest that many physicians, let alone many patients, are uninformed about the costs of cancer care. Greater cost transparency and both physician and patient education will be necessary to improve patient understanding of costs and to reduce financial burdens. While many patients wish to discuss costs of care, few report such conversations, and there is no consensus on the optimal setting, timing, content or goals for such discussions. This paper reviews the challenge of appropriately educating patients regarding financial burdens of cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available